Cmed is currently working on a Phase II trial with a US Pharmaceutical company involving pediatric patients with selected inherited metabolic disorders undergoing stem cell transplantation.
Discover how Cmed is uniquely managing this challenging study in the areas of:
- Enrolment
- IMP supply
- Medical Monitoring
Click here to see the case study: Cmed Rare Disease Case Study_Phase II Pediatric Study with Selected Metabolic Disorders
